Detalhe da pesquisa
1.
Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled study.
Neurourol Urodyn
; 34(1): 37-43, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24133005
2.
Efficacy and safety of oxybutynin chloride topical gel for women with overactive bladder syndrome.
Am J Obstet Gynecol
; 206(2): 168.e1-6, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21963104
3.
Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms.
Neurourol Urodyn
; 30(7): 1214-9, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21462240
4.
Fesoterodine in patients with overactive bladder syndrome: can the severity of baseline urgency urinary incontinence predict dosing requirement?
BJU Int
; 106(6): 816-21, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20151972
5.
Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
J Urol
; 181(4): 1764-72, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19233423
6.
The evolution of transdermal therapy for overactive bladder.
Curr Urol Rep
; 10(5): 338-41, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19709479
7.
Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome.
J Urol
; 178(6): 2488-94, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17937959
8.
Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials.
Int Urol Nephrol
; 39(4): 1069-77, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17333521
9.
Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
Clin Ther
; 28(11): 1935-46, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17213014
10.
Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial.
Mayo Clin Proc
; 78(6): 687-95, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12934777
11.
Elevating our therapeutic expectations in overactive bladder.
J Am Acad Nurse Pract
; 16(10 Suppl): 8-11, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15543927
12.
Long-term safety, tolerability and efficacy of fesoterodine in subjects with overactive bladder symptoms stratified by age: pooled analysis of two open-label extension studies.
Drugs Aging
; 29(2): 119-31, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22276958
13.
Foreign-body granuloma after injection of calcium hydroxylapatite for type III stress urinary incontinence.
Obstet Gynecol
; 118(2 Pt 2): 418-421, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21768839
14.
Extrasphincteric perianal fistulae after sacrospinous fixation for apical prolapse.
Obstet Gynecol
; 117(2 Pt 2): 438-440, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21252781
15.
Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms.
Curr Med Res Opin
; 27(5): 921-30, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21355814
16.
Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndrome.
Int Urogynecol J Pelvic Floor Dysfunct
; 20(12): 1431-8, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19727537
17.
Efficacy and tolerability of fesoterodine in women with overactive bladder.
Int Urogynecol J Pelvic Floor Dysfunct
; 20(7): 827-35, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19495545
18.
Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional study.
Urology
; 71(3): 449-54, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18342185
19.
A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women.
Int Urogynecol J Pelvic Floor Dysfunct
; 15(4): 243-8, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15517668
20.
Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence.
Urology
; 62(2): 237-42, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12893326